Early-to-midlife infections that require hospital care are associated with an increased risk of developing Alzheimer's and Parkinson's disease later in life, a new study reports.
Study reveals a novel mechanism in locus coeruleus neurons caused by the loss of the GPT2 mitochondrial enzyme that is implicated in the development and progression of neurodegenerative diseases.
Dampening retromer activity slows down the trafficking of tau in neurodegenerative disorders, a new study reports.
A 20-minute session of non-invasive brain stimulation over four days helps to improve both working and long-term memory in those aged 65 and older.
Researchers discuss current studies about cognitive rejuvenation and discuss steps we can take to help protect our brains as we age.
An older person's posture may give clues to hidden cognitive decline, a new study reports.
The aged non-human primate hippocampus showed signs of increased inflammation, genomic and epigenomic instability, and a loss of proteostasis.
Researchers have identified the cellular and molecular mechanisms that regulate selective autophagy.
NU-9, an experimental drug, appears to be more effective at treating ALS than existing medications.
Study reveals a new mechanism that appears to reverse the build-up of protein aggregates by refolding them, rather than removing them.
Amyloid fibrils in those with frontotemporal lobar degeneration (FTLD) contain a little-known protein called TMEM106B. Researchers speculate TMEM106B could be found to be the cause of FTLD.
An abundance of newly acquired mutations in the mutations that occur at an accelerated speed is a telling pattern of Alzheimer's disease, researchers report.
